Core Insights - Guangzhou Pharmaceutical Holdings Limited has established a new subsidiary, Guangyao Yunshan Molecular Technology (Guangzhou) Co., Ltd, with a registered capital of 500 million RMB [1] Company Overview - The legal representative of the new company is Kong Jian [1] - The company is wholly owned by Baiyunshan (600332) [1] Business Scope - The business activities include medical research and experimental development, technical services, technical development, technical consulting, technical communication, technology transfer, and technology promotion [1] - The company will also engage in investment activities using its own funds, sales of Class II medical devices, internet sales of food, and food sales [1]

天眼查App显示，近日，武汉市洪山区润普济中医药研究坊（个体工商户）成立，法定代表人为杨宁， 注册资本1万人民币，经营范围为一般项目：医学研究和试验发展，农副产品销售，农产品的生产、销 售、加工、运输、贮藏及其他相关服务，食用农产品初加工，食用农产品零售，外卖递送服务，互联网 销售（除销售需要许可的商品）。（除许可业务外，可自主依法经营法律法规非禁止或限制的项目）许 可项目：食品销售，食品小作坊经营，豆制品制造，餐饮服务。（依法须经批准的项目，经相关部门批 准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）。 ...

Core Viewpoint - Recently, Guoxin Medical Technology (Wuxi) Co., Ltd. was established with a registered capital of 5 million RMB, fully owned by Guoxin Medical Technology (Beijing) Co., Ltd. [1][2] Company Information - The legal representative of Guoxin Medical Technology (Wuxi) Co., Ltd. is Song Wei [1] - The registered capital of the company is 5 million RMB [1] - The company is located at No. 1699, Huishan Avenue, Building 2, 3rd Floor, Huishan Economic Development Zone, Wuxi [2] - The company is classified as a limited liability company (wholly owned by a natural person) [2] - The business scope includes medical research and experimental development, technical services, technology transfer, sales of first and second-class medical devices, and various consulting services [2] Shareholding Structure - Guoxin Medical Technology (Beijing) Co., Ltd. holds 100% of the shares in Guoxin Medical Technology (Wuxi) Co., Ltd. [2]